Skip to main content
Top
Published in: Annals of Surgical Oncology 13/2022

04-08-2022 | Breast Cancer | ASO Author Reflections

ASO Author Reflections: Residual Cancer Burden Across Phenotypic Subtypes

Authors: E. Alexa Elder, MD, Richard White, MD

Published in: Annals of Surgical Oncology | Issue 13/2022

Login to get access

Excerpt

The residual cancer burden (RCB) was developed as a standard scoring system to report residual disease burden at surgery after neoadjuvant chemotherapy.1 The utility of this scoring system in the context of different breast cancer phenotypes was not well established. …
Literature
1.
go back to reference Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25(28):4414–22.CrossRefPubMed Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25(28):4414–22.CrossRefPubMed
3.
go back to reference Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre polled analysis of 5161 patients. Lancet. 2022;23:149–60.CrossRef Yau C, Osdoit M, van der Noordaa M, et al. Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre polled analysis of 5161 patients. Lancet. 2022;23:149–60.CrossRef
Metadata
Title
ASO Author Reflections: Residual Cancer Burden Across Phenotypic Subtypes
Authors
E. Alexa Elder, MD
Richard White, MD
Publication date
04-08-2022
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 13/2022
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12334-1

Other articles of this Issue 13/2022

Annals of Surgical Oncology 13/2022 Go to the issue